SCHEMBL6034749

SCHEMBL6034749

CCCCC(NC(=O)CCSSc1ccccn1)C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 15/20 0.44
HDAC2 Q92769 13/20 0.44
HDAC6 Q9UBN7 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30179538 0.86 HDAC1 (0.39) HDAC1HDAC2HDAC6
SCHEMBL898975 0.82 HDAC2 (0.47) HDAC1HDAC2
SCHEMBL4020381 0.80 HDAC1 (0.36) HDAC1HDAC2
SCHEMBL29486519 0.79 HDAC1 (0.36) HDAC1HDAC2HDAC6
SCHEMBL15994284 0.77 HPGD (0.38) HDAC1HDAC2
SCHEMBL15661274 0.77 HDAC1 (0.35) HDAC1HDAC2
SCHEMBL42368 0.77 ALDH1A1 (0.44) HDAC1HDAC2
SCHEMBL29352062 0.77 ALDH1A1 (0.44) HDAC1HDAC2
SCHEMBL9926762 0.76 HDAC1 (0.39) HDAC1HDAC2HDAC6
SCHEMBL31005443 0.76 HPGD (0.43) HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4687843-A1 FORMULATIONS AND USES THEREOF Sartorius Albumedix Limited (GB) 2026-02-11 EP disclosed
US-12116400-B2 Albumin variants and conjugates SARTORIUS ALBUMEDIX LIMITED (GB) 2024-10-15 US disclosed
WO-2024209085-A1 FORMULATIONS AND USES THEREOF ALBUMEDIX LTD (GB) 2024-10-10 WO disclosed
EP-4442251-A1 FORMULATIONS AND USES THEREOF Albumedix Ltd (GB) 2024-10-09 EP disclosed
WO-2024092001-A1 CD33 ANTIBODY COMPOSITIONS FOR TREATING ALZHEIMER'S DISEASE MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2024-05-02 WO disclosed
EP-3243835-B1 ALBUMIN VARIANTS AND CONJUGATES ALBUMEDIX LTD (GB) 2024-04-10 EP disclosed
EP-3337816-B1 ALBUMIN VARIANTS AND CONJUGATES ALBUMEDIX LTD (GB) 2024-02-14 EP disclosed
EP-4308160-A2 METHODS FOR TREATING GYNECOLOGIC CANCER USING COMBINATION THERAPY WITH ANTI-MUC16 X CD3 MULTISPECIFIC ANTIBODIES AND VEGF INHIBITORS Memorial Sloan-Kettering Cancer Center (US) 2024-01-24 EP disclosed
EP-4277664-A1 ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE Memorial Sloan Kettering Cancer Center (US) 2023-11-22 EP disclosed
EP-4277665-A1 ANTI-DLL3 ANTIBODY-DRUG CONJUGATE Memorial Sloan Kettering Cancer Center (US) 2023-11-22 EP disclosed
WO-2016144352-A2 THERAPEUTIC COMPOSITIONS INCLUDING ACRYLAMIDO COMPOUNDS OR PHENYL-SUBSTITUTED MALEIMIDE COMPOUNDS, VARIANTS THEREOF AND METHODS OF USING THE SAME STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2016-09-15 WO disclosed
WO-2016004093-A2 THERAPEUTIC COMPOSITIONS INCLUDING GALECTIN-3 INHIBITORS AND USES THEREOF STEALTH BIOTHERAPEUTICS CORP (MC) 2016-01-07 WO disclosed
WO-2015183970-A1 THERAPEUTIC COMPOSITIONS INCLUDING FLAVONOID AND USES THEREOF STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2015-12-03 WO disclosed
WO-2015183995-A2 THERAPEUTIC COMPOSITIONS INCLUDING FRATAXIN, LACTOFERRIN, AND MITOCHONDRIAL ENERGY GENERATING ENZYMES, AND USES THEREOF STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2015-12-03 WO disclosed
WO-2015183988-A1 THERAPEUTIC COMPOSITIONS INCLUDING THERAPEUTIC SMALL MOLECULES AND USES THEREOF STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2015-12-03 WO disclosed
WO-2015183963-A2 THERAPEUTIC COMPOSITIONS INCLUDING REDOX-ACTIVE PARABENZOQUINONES AND USES THEREOF STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2015-12-03 WO disclosed
WO-2015183985-A2 THERAPEUTIC COMPOSITIONS INCLUDING NAPHTHOQUINONES AND USES THEREOF STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2015-12-03 WO disclosed
WO-2015183984-A2 THERAPEUTIC COMPOSITIONS INCLUDING TOCOPHEROL AND USES THEREOF STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2015-12-03 WO disclosed
EP-1625149-A2 METHOD AND CARRIER COMPLEXES FOR DELIVERING MOLECULES TO CELLS CORNELL RESEARCH FOUNDATION, INC. (US) 2006-02-15 EP disclosed
WO-2005001023-A2 METHOD AND CARRIER COMPLEXES FOR DELIVERING MOLECULES TO CELLS CORNELL RESEARCH FOUNDATION, INC. (US) 2005-01-06 WO disclosed